Xarelto · DIN 02378604 · 15 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Savings card: innoviCares lists Xarelto (Ontario list dated 2026-09-10) — pays part of the brand-versus-generic difference after other coverage; free sign-up. (innovicares.ca ↗)
Savings card: RxHelp ONE lists Xarelto (read 2026-09-10) — brand-name savings card, free; cannot be combined with another card on the same claim. (rxhelp.ca ↗)
Limit of one Prescription Drug Card Program / Patient Financial Assistance Card from any adjudicator per DIN and claim submitted. The RxHelpONE card CANNOT be combined with any other card or offer. (Terms of Use) (rxhelp.ca, September 10, 2026 ↗)
1 brand, same coverage
Xarelto · DIN 02378604
Manufacturer: Bayer Inc., Health Care Division; listing date 2012-07-27
Health Canada: Marketed since 2012-01-17 · brand XARELTO · ATC B01AF01 RIVAROXABAN · form Tablet · route Oral · ingredients RIVAROXABAN 15 MG · company Bayer inc · schedule Prescription
Ministry pays: $0.7175 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02378604)
Source record
DIN 02378604: Xarelto
Raw flags: sec3=Y
Item: 201200086; group id 259; item number 0508; lccId None; manufacturer id BAH
Source form: Tab; strength: 15mg
Recorded listing: General benefit
Source prices (unrounded): $2.8700; ministry $0.7175
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02378604
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=86439
Interchangeable products
Apo-Rivaroxaban · DIN 02470500 · $0.7175
Auro-Rivaroxaban · DIN 02560364 · $0.7175
Bio-Rivaroxaban · DIN 02549344 · $0.7175
Jamp Rivaroxaban · DIN 02516306 · $0.7175
M-Rivaroxaban · DIN 02551624 · $0.7175
PMS-Rivaroxaban · DIN 02512068 · $0.7175
Reddy-Rivaroxaban · DIN 02472430 · $0.7175
Rivaroxaban · DIN 02541483 · $0.7175
Rivaroxaban · DIN 02547910 · $0.7175
Sandoz Rivaroxaban · DIN 02482231 · $0.7175
Taro-Rivaroxaban · DIN 02483815 · $0.7175
Teva-Rivaroxaban · DIN 02507218 · $0.7175
Shortage status: resolved shortage (ended February 7, 2023); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02378604
Shortage record checked October 6, 2026